LAS VEGAS, NV—An endovascular approach for the treatment of long, complex superficial femoropopliteal lesions that incorporates surgical principles results in good patency through 3 years with no late ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, Inc., today announced it has received conditional approval of its investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, today announced CE (Conformité Européenne) Mark approval for a trio of proprietary devices: TORUS™ Stent Graft System, PQ Snare, and PQ Crossing Device, ...
One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results